Strategic Footprint Canada-wide distribution network across seven key centers (Vancouver, Calgary, Regina, Winnipeg, Toronto, Montreal, Moncton) presents opportunities to upsell cross-border or cross-regional pharmaceutical and healthcare product lines to manufacturers seeking national coverage and consistent service levels.

Healthcare Focus Position Kohl & Frisch as the essential distribution partner for Rx, OTC, HHC, and front-shop needs to manufacturers targeting healthcare providers, clinics, and hospitals, leveraging its established relationships with chain retailers and independent pharmacies.

Tech-Enabled Advantage Leverage the company’s emphasis on technology and innovation (including SharePoint, OneDrive, Teams, and modern web/advertising tools) to offer scalable, compliant e-commerce, digital cataloging, and real-time inventory visibility to manufacturers and customers.

Leadership Growth Recent senior appointment in 2022 of a SVP for Manufacturer Relations and Regulatory Affairs signals commitment to regulatory expertise and strong manufacturer partnerships, enabling proactive regulatory support and faster time-to-market for partner products.

Financial Scale Revenue in the $50M–$100M range with 201–500 employees places Kohl & Frisch as a mid-market distributor capable of handling sizable national supply contracts, enabling sales reps to target mid-to-large manufacturers seeking reliable national distribution and competitive pricing.